Antibiotic resistance

Bacteria develop resistance through several biochemical mechanisms, each enabling survival in the presence of antibiotics. The primary mechanisms include enzymatic inactivation of the drug, alteration of the drug target, reduced permeability to the drug, and active efflux pumps that expel the antibiotic from the cell¹. For example, beta-lactamases are enzymes that hydrolyze the beta-lactam ring of penicillins and cephalosporins, rendering them ineffective. Target alteration is exemplified by mutations in penicillin-binding proteins (PBPs) in methicillin-resistant Staphylococcus aureus (MRSA), which reduce binding affinity. Efflux pumps, such as the AcrAB-TolC system in Escherichia coli, can extrude multiple drug classes, contributing to multidrug resistance.

Antibiotic resistance is a major global health threat, with an estimated 1.27 million deaths directly attributable to bacterial antimicrobial resistance (AMR) in 2019, and 4.95 million associated deaths². The burden is disproportionately high in low- and middle-income countries, particularly in sub-Saharan Africa and South Asia. Common resistant pathogens include Escherichia coli, Klebsiella pneumoniae, and Staphylococcus aureus, which cause infections such as pneumonia, bloodstream infections, and urinary tract infections. The economic impact is also substantial, with increased healthcare costs, prolonged hospital stays, and loss of productivity.

The primary driver of antibiotic resistance is the overuse and misuse of antibiotics in human medicine, agriculture, and animal husbandry. In many countries, antibiotics are available without prescription, leading to inappropriate use for viral infections. In agriculture, antibiotics are used for growth promotion and disease prevention in livestock, contributing to the selection of resistant bacteria that can spread to humans through the food chain and environment³. Poor infection control practices in healthcare settings also facilitate the transmission of resistant strains.

Addressing antibiotic resistance requires a multifaceted approach, including antimicrobial stewardship programs to optimize antibiotic use, infection prevention and control measures, surveillance of resistance patterns, and the development of new antibiotics and alternative therapies⁴. The World Health Organization (WHO) has developed a Global Action Plan on AMR, urging countries to implement national action plans. Additionally, research into bacteriophage therapy, vaccines, and immunotherapies offers promising avenues. Public education and international cooperation are essential to curb the spread of resistance.

Beyond the well-known mechanisms, antibiotic resistance has several lesser-known dimensions. For instance, resistance can be intrinsic, as seen in Pseudomonas aeruginosa which has low outer membrane permeability, or acquired via horizontal gene transfer through plasmids, transposons, and integrons. The role of the environment is often overlooked: antibiotic residues and resistant bacteria from human and animal waste contaminate water and soil, creating reservoirs of resistance genes that can be transferred back to human pathogens⁵. Additionally, the phenomenon of heteroresistance, where a subpopulation of bacteria is resistant while the majority is susceptible, can lead to treatment failure. The discovery of antibiotics from unculturable soil bacteria, such as teixobactin, highlights the potential of novel sources, but also underscores the need for sustainable discovery. Historical perspectives reveal that even Alexander Fleming warned about the dangers of misuse in his 1945 Nobel lecture, yet the problem has persisted and intensified.

Antimicrobial resistance (AMR)

The broader phenomenon of resistance in microbes (bacteria, viruses, fungi, parasites) to drugs used to treat them.

Beta-lactamase

An enzyme produced by bacteria that inactivates beta-lactam antibiotics by hydrolyzing the beta-lactam ring.

Horizontal gene transfer

The movement of genetic material between bacteria other than by vertical transmission (parent to offspring), often via plasmids or transposons.

Efflux pump

A membrane protein that actively transports antibiotics out of the bacterial cell, reducing intracellular drug concentration.

Heteroresistance

A phenomenon where a bacterial population contains a subpopulation of resistant cells, which can cause treatment failure despite apparent susceptibility.